Search Browse Earnings

STANDARD BIOTOOLS INC.

Nasdaq:LAB

Laboratory Analytical Instruments·BOSTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

STANDARD BIOTOOLS INC. — SlamSEC

Revenue

$97.9M

+0.0% YoY

FY 2024

Adj. EBITDA

-$103.8M

-105.9% margin

FY 2024

Net Income

-$190.1M

-194.1% margin

FY 2024

EPS (Diluted)

-$2.43

FY 2024

Stock Price

$0.99

-2.9%

2026-03-06

52W Range

$0.92 – $1.72

P/E Ratio

-0.4x

Market Cap

$380.7M

Cash

$51.7M

FY 2024

Total Debt

$1.2M

FY 2012

Net Cash

$50.5M

FY 2012

Enterprise Value

$330.3M

Debt / EBITDA

0.5x

FY 2024

EV / EBITDA

-3.2x

Employees

—